Department of Translational Biomedicine and Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
School of Dentistry, University of Dundee, Dundee, Scotland, UK.
J Dent Res. 2024 May;103(5):461-466. doi: 10.1177/00220345241236125. Epub 2024 Apr 7.
A subset of bacterial species that holds genes encoding for β-glucuronidase and β-galactosidase, enzymes involved in the metabolism of conjugated estrogens, is called the "estrobolome." There is an emerging interest embracing this concept, as it may exert a selective impact on a number of pathologies, including oral cancer. Although the estrobolome bacteria are typically part of the gut microbiota, recent experimental pieces of evidence have suggested a crosstalk among oral and gut microbiota. In fact, several oral bacterial species are well represented also in the gut microbiota, and these microbes can effectively induce the estrobolome activation. The main pathways used for activating the estrobolome are based on the induction of the expression patterns for 2 bacterial enzymes: β-glucuronidase and aromatase, both involved in the increase of estrogen released in the bloodstream and consequently in the salivary compartment. Mechanistically, high estrogen availability in saliva is responsible for an increase in oral cancer risk for different reasons: briefly, 1) estrogens directly exert biological and metabolic effects on oral mucosa cells; 2) they can modulate the pathological profile of some bacteria, somewhere associated with neoplastic processes (i.e., spp., ssp.); and 3) some oral bacteria are able to convert estrogens into carcinogenic metabolites, such as 4-hydroxyestrone and 16α-hydroxyestrone (16α-OHE), and can also promote local and systemic inflammation. Nowadays, only a small number of scientific studies have taken into consideration the potential correlations among oral dysbiosis, alterations of the gut estrobolome, and some hormone-dependent cancers: this lack of attention on such a promising topic could be a bias affecting the full understanding of the pathogenesis of several estrogen-related oral pathologies. In our article, we have speculated on the activity of an oral-gut-estrobolome axis, capable of synergizing these 2 important microbiotas, shedding light on a pilot hypothesis requiring further research.
一组具有编码β-葡糖苷酸酶和β-半乳糖苷酶基因的细菌被称为“雌甾醇组”,这些酶参与共轭雌激素的代谢。人们对这个概念越来越感兴趣,因为它可能对包括口腔癌在内的许多病理产生选择性影响。尽管雌甾醇组细菌通常是肠道微生物群的一部分,但最近的一些实验证据表明,口腔和肠道微生物群之间存在相互作用。事实上,一些口腔细菌也广泛存在于肠道微生物群中,这些微生物可以有效地诱导雌甾醇组的激活。激活雌甾醇组的主要途径是基于诱导 2 种细菌酶的表达模式:β-葡糖苷酸酶和芳香酶,这两种酶都参与增加血液中释放的雌激素,并因此增加唾液中的雌激素。从机制上讲,唾液中高雌激素水平会导致口腔癌风险增加,原因有以下几点:1)雌激素直接对口腔黏膜细胞发挥生物学和代谢作用;2)它们可以调节与肿瘤过程相关的某些细菌的病理特征(即 spp.,ssp.);3)一些口腔细菌能够将雌激素转化为致癌代谢物,如 4-羟基雌酮和 16α-羟基雌酮(16α-OHE),并能促进局部和全身炎症。目前,只有少数科学研究考虑了口腔微生态失调、肠道雌甾醇组改变与某些激素依赖性癌症之间的潜在相关性:对这一有前途的课题缺乏关注可能是影响对几种与雌激素相关的口腔病理发病机制的全面理解的一个偏见。在我们的文章中,我们推测了一个口腔-肠道-雌甾醇组轴的活性,它能够协同这两个重要的微生物群,为一个需要进一步研究的初步假设提供了线索。
J Dent Res. 2024-5
Int J Mol Sci. 2023-11-14
Hum Reprod Update. 2021-12-21
Crit Rev Toxicol. 2024-9
Healthcare (Basel). 2025-6-11